Canada needs to renew its relationship with its pharmaceutical industry

Because of COVID-19, countries around the world have recognized the contribution that a strong life sciences sector makes to the health and well-being of their citizens and their economies. Canada is no different. Our country’s economic future will be driven by a robust life sciences sector with companies working at the forefront of knowledge and technology, and driving economic growth through significant investments in research and innovation.

Read the article

Previous
Previous

Building resilient health systems in Africa beyond the COVID-19 pandemic response

Next
Next

WHO and Canada: Working together to end the acute phase of the COVID-19 and equipping countries to emerge from the pandemic with stronger and more equitable health systems